PostE largely reduced the high expressions of PCK‐1 (***p < .001 at 1 day, *p < .05 at 3 days, Figure 3a) as well as PCK‐2 (***p < .001 at 1 and 3 days, Figure 3b) after stroke. The gene discussed is PCK1; the disease is stroke disorder.